We investigated the processing enzymes involved in the formation of circulating angiotensin-(l-7) after intravenous administration of angiotensin I to conscious spontaneously hypertensive and Wistar-Kyoto rats. Immunoreactive products, including angiotensin I, angiotensin II, and angiotensin-(l-7), were measured in arterial blood by three specific radioimmunoassays. Angiotensin I infusion (2 nmol) induced a rapid increase in immunoreactive angiotensin II and angiotensin-(l-7). Pretreatment with the angiotensin converting enzyme inhibitor enalaprilat (2 mg/kg) eliminated angiotensin II formation and augmented circulating levels of angiotensin I and angiotensin-(l-7) in spontaneously hypertensive and Wistar-Kyoto rats. The elevated levels of angiotensin-(l-7) in enalaprilat-treated rats were blocked by concurrent treatment with the neutral endopeptidase (EC 3.4.24.11) inhibitor SCH 39,370 (15 mg/kg) in both strains. Administration of SCH 39,370 alone decreased angiotensin-(l-7) levels in spontaneously hypertensive rats, whereas angiotensin II levels increased in both strains (p<0.01). Comparisons of the metabolism of angiotensin I in the two rat strains showed increased formation of angiotensin-(l-7) in spontaneously hypertensive rats not given any of the enzyme inhibitors. In addition, levels of angiotensin I were higher after administration of SCH 39,370 in hypertensive rats. These novel findings reveal that neutral endopeptidase EC 3.4.24.11 participates in the conversion of angiotensin I to angiotensin-(l-7) and in the metabolism of angiotensin II in the circulation of both spontaneously hypertensive and Wistar-Kyoto rats. Our results suggest that neutral endopeptidase EC 3.4.24.11 is a major enzymatic constituent of the circulating renin-angiotensin system. (Hypertension 1992;19:692-696) KEY WORDS • angiotensin I • angiotensin II • angiotensin converting enzyme • enalaprilat • enzyme inhibitors • peptide peptidohydrolases • spontaneously hypertensive rats A ngiotensin-(l-7) ] is the first member / \ of the angiotensin peptide family to cause cells -Z \ -to secrete hormones and release autacoids without eliciting accompanying changes in blood pressure, water intake, and aldosterone secretion. Incubation of hypothalamic explants with Ang-(l-7) stimulates a dose-dependent release of vasopressin.